Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T19:56:23.384Z.
Calculation as of: 2026-10-06T19:56:23.384Z.
Quote observation: 2026-10-06T19:54:54.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4cebeea1a9b4d788b134268ad244658713bcf5e38577c227b803d15950d20ec6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Market Cap
$5.68M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.90M
PS Ratio
408.59
TTM Avg
323.54
3Y Avg
12621.52
5Y Avg
612402.72
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $5.68M | N/A | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.86M | 1.72 | 2.25 | 4.05 | 7.26 |
| enVVeno Medical Corporation (NVNO)vs › | $5.76M | N/A | 4.26 | 3.43 | 3.43 |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.79M | 0.26 | 0.24 | 0.25 | 0.59 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.56M | N/A | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.85M | N/A | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.90M | 408.59 | 323.54 | 12621.52 | 612402.72 |
| Soligenix, Inc. (SNGX)vs › | $5.33M | N/A | 41.56 | 161.30 | 129.34 |
| Pulmatrix, Inc. (PULM)vs › | $5.19M | N/A | 1549.76 | 519.51 | 312.87 |
| Scienture Holdings, Inc. (SCNX)vs › | $6.01M | 7.32 | 114.61 | 78.12 | 78.12 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
